BioCryst Pharmaceuticals | BCRX - Ebitda





Ebitda Cambiamento Data
Alnylam Pharmaceuticals USD 245.34M 59.15M 2026-06
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Chugai Pharma JPY 158.77B 10.24B 2026-03
Daiichi Sankyo JPY 101.6B 22.81B 2025-03
DBV Technologies USD -45.9M 12.42M 2026-03
Gilead Sciences USD 3.51B 489M 2026-03
GlaxoSmithKline GBP 3.51B 734M 2026-06
Glaxosmithkline GBP 2.77B 1.98B 2026-03
Incyte USD 778.57M 410.6M 2026-06
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Novavax USD 19.36M 190.79M 2025-12
PTC Therapeutics USD 61.98M 132.97M 2026-03
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sarepta Therapeutics USD 375.48M 627.68M 2026-03
Ultragenyx Pharmaceutical USD -155M 55.57M 2026-03
Vertex Pharmaceuticals USD 1.33B 130.5M 2026-06